PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Aug-2023 AlzeCure publishes the positive clinical results from the phase I trial of NeuroRestore ACD856 against Alzheimer's AlzeCure Pharma AB
09-Aug-2023 Astex Expands Drug Discovery Collaboration With MSD Astex Pharmaceuticals (UK)
09-Aug-2023 STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition STORM Therapeutics
09-Aug-2023 Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapies Cell and Gene Therapy Catapult
09-Aug-2023 Correction of technical issuing details of the final terms in the rights issue Euroclear Sweden AB
09-Aug-2023 SMC accepts VAZKEPA®▼(icosapent ethyl) to help reduce the risk of heart attacks and strokes for patients in Scotland1 Amarin
09-Aug-2023 Surging demand for Korean pharma in 2023 ahead of CPHI Korea CPHI
09-Aug-2023 IO Biotech, Inc. Announces $75 Million Private Placement Financing IO Biotech
09-Aug-2023 TWO KEY MEDICINES FOR SEVERE ASTHMA AND CHRONIC HEART FAILURE ACCEPTED FOR USE IN SCOTLAND BY THE SCOTTISH MEDICINES CONSORTIUM AstraZeneca
09-Aug-2023 Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd. Marinomed Biotech AG
09-Aug-2023 SYNLAB AG: Continued strong performance in the second quarter of 2023 SYNLAB AG
09-Aug-2023 Kuros Biosciences Reports Results for First Half 2023 Kuros Biosciences AG
09-Aug-2023 STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023 STRATEC SE
08-Aug-2023 Heidelberg Pharma AG: Heidelberg Pharma’s Partner Takeda Reached Development Milestone Heidelberg Pharma AG
08-Aug-2023 Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe Biophytis
07-Aug-2023 TWO KEY MEDICINES FOR SEVERE ASTHMA AND CHRONIC HEART FAILURE ACCEPTED FOR USE IN SCOTLAND BY THE SCOTTISH MEDICINES CONSORTIUM AstraZeneca
07-Aug-2023 Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar Formycon AG
07-Aug-2023 Cannovum Cannabis AG: Exclusive partnership and million-dollar sales potential with Cannabis Club Association. Cannovum Cannabis AG
04-Aug-2023 IGEA Pharma N.V.: IGEA to update on SIX decision IGEA Pharma N.V.
04-Aug-2023 Cognizant expands generative AI partnership with Google Cloud, announces development of healthcare large language model solutions Cognizant